Jerlhag E (2018) GLP-1 signaling and alcohol-mediated behaviors
Shima Hadidchi, MD, Explains the Science Behind This Weight Loss Option Is Zepbound a GLP-1 medication
Help protect your patients by reducing their risk of CKD progression 1,2 1,2 For adults with T2D, for the primary composite endpoint: Time to first occurrence of 50% sustained eGFR decline, kidney failure (sustained eGFR 100 mg/g and 300 mg/g at baseline)
Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: A systematic review and network meta-analysis
Get a personalized plan designed for real, lasting results
Personalized Dosing: The Role of Genetic Testing The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways